Skip to main content
All lobbying filings

HOLLAND & KNIGHT LLP

HOLLAND & KNIGHT LLP filed a Q4 report for CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. on January 11, 2026, reporting $80,000 in lobbying income.

Lobbying for CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Biotechnology

All filings by HOLLAND & KNIGHT LLP · Everything CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 11, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
Tennessee

Official filing document

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act (S. 2561 / H.R. 5768).

 Bills named in this filing 2
  • S. 2561
    Skin Substitute Access and Payment Reform Act of 2025
  • H.R. 5768
    Skin Substitute Access and Payment Reform Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem